Note 2 – Summary of Significant Accounting Policies –
(Cont.)
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 – Restatement of Financial Statements
The Company concluded it should restate its previously issued financial statements by amending its Quarterly Report on Form
10-Q,
filed with the SEC on August 10, 2021, to classify all Public Shares in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, ASC 480, paragraph
10-S99,
redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Public Shares in permanent equity, or total stockholders’ equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that, the Company will not redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001. Previously, the Company did not consider redeemable stock classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. Also, in connection with the change in presentation for the Public Shares, the Company also revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares share pro rata in the income and losses of the Company. As a result, the Company restated its previously filed financial statements to present all redeemable common stock as temporary equity and to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering and in accordance with ASC 480.
Impact of the Restatement
The Company’s statement of stockholders’ equity has been restated to reflect the changes to the impacted stockholders’ equity accounts described above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - December 31, 2020 (Restated)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss (Restated)
|
|
|
(1,015,510
|
)
|
|
|
(1
|
)
|
|
|
(1,015,511
|
)
|
Change in value of common stock subject to possible redemption (Restated)
|
|
|
(3,651,392
|
)
|
|
|
3,651,392
|
|
|
|
—
|
|
Balance as of March 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss (Restated)
|
|
|
(1,043,471
|
)
|
|
|
—
|
|
|
|
(1,043,471
|
)
|
Balance as of June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the period from January 1, 2021 through June 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Period from January 1, 2021 through June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosure of Noncash Financing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in value of common stock subject to possible redemption (restated)
|
|
$
|
3,651,391
|
|
|
$
|
(3,651,391
|
)
|
|
$
|
—
|
|
The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per share is presented below for the three and six months ended June 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share for Common Stock
|
|
|
As Previously
Reported
(1)
|
|
|
|
|
|
|
|
For the Three Months Ended June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,043,472
|
)
|
|
$
|
1
|
|
|
$
|
(1,043,471
|
)
|
Basic and Diluted weighted-average redeemable common shares outstanding
|
|
|
17,000,000
|
|
|
|
—
|
|
|
|
17,000,000
|
|
Basic and Diluted net loss per redeemable common share
|
|
$
|
(0.00
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
Basic and Diluted weighted-average
non-redeemable
common shares outstanding
|
|
|
4,478,000
|
|
|
|
—
|
|
|
|
4,478,000
|
|
Basic and Diluted net loss per
non-redeemable
common shares
|
|
$
|
(0.23
|
)
|
|
$
|
0.18
|
|
|
$
|
(0.05
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings Per Share for Common Stock
|
|
|
As Previously
Reported
(1)
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(2,058,982
|
)
|
|
$
|
—
|
|
|
$
|
(2,058,982
|
)
|
Basic and Diluted weighted-average redeemable common shares outstanding
|
|
|
16,818,439
|
|
|
|
181,561
|
|
|
|
17,000,000
|
|
Basic and Diluted net loss per redeemable common share
|
|
$
|
(0.00
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.10
|
)
|
Basic and Diluted weighted-average
non-redeemable
common shares outstanding
|
|
|
4,659,492
|
|
|
|
(181,492
|
)
|
|
|
4,478,000
|
|
Basic and Diluted net loss per
non-redeemable
common shares
|
|
$
|
(0.44
|
)
|
|
$
|
0.34
|
|
|
$
|
(0.10
|
)
|
(1) - The weighted average shares outstanding was calculated based on the
two-class
method, where the earnings per share was determined based on redeemable and
non-redeemable
common stock. The Company revised its earnings per share calculation to allocate net losses by the weighted average shares of redeemable and
non-redeemable
common stock outstanding for the respective period.
Note 4 – Initial Public Offering
Pursuant to the IPO on October 22, 2020, the Company sold 15,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of common stock and
one-half of
one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment.
The underwriters were granted a
45-day
option from the date of the prospectus (the “Over-Allotment Option”) to purchase up to 2,250,000 additional units to cover over-allotments (the “Over-Allotment Units”), if any. On October 26, 2020, the underwriters partially exercised the over-allotment option by purchasing 1,500,000 Units (the “Over-Allotment Units”), and on November 17, 2020, the underwriters exercised a final over-allotment option and purchased an additional 500,000 Over-Allotment Units, generating aggregate of gross proceeds of $20,000,000.
Upon closing of the IPO and the sale of the Over-Allotment Units, a total of $170,000,000 ($10.00 per Unit) has been placed in a U.S.-based trust account, with Continental Stock Transfer & Trust Company acting as trustee.
Note 5 – Private Placement
On October 22, 2020, simultaneously with the closing of the Public Offering, the Anchor Investors purchased an aggregate of 228,000 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,280,000, in a private placement that occurred simultaneously with the closing of the Public Offering. Each Private Unit consists of one share of common stock (“Private Share”) and
one-half
of one warrant (“Private Warrant”). Each whole Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per share, subject to adjustment. The proceeds from the Private Units were added to the proceeds from the Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).
Note 6 – Related Party Transactions
In July 2020, Sponsor, and our officers and directors (collectively, the “Founders”) purchased an aggregate of 4,312,500 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. In August 2020, certain of our initial stockholders forfeited 1,355,000 Founder Shares and the Anchor Investors purchased 1,355,000 Founder Shares for an aggregate purchase price of approximately $7,855, or approximately $0.006 per share. In October 2020, Sponsor forfeited an aggregate of 562,500 founder shares for no consideration, and GW Sponsor 2, LLC, an entity managed by Management, purchased from the Company 562,500 shares for a purchase price of $163,125. The Founder Shares include an aggregate of up to 562,500 shares subject to forfeiture by Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the Founders and Anchor Investors will collectively own 20% of the Company’s issued and outstanding shares after the Public Offering (assuming the Founders or Anchor Investors do not purchase any Public Shares in the Public Offering). On November 17, 2020, the underwriters canceled the remainder of the Over-Allotment Option. In connection with the cancellation of the remainder of the Over-Allotment Option, the Company cancelled an aggregate of 62,500 shares of common stock issued to Sponsor.
16